Flare Therapeutics Stock

www.flaretx.com/HealthcareFounded: 2021Funding to Date: $207MM

Flare Therapeutics is a biotechnology company seeking to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the work of its scientific founders, Flare’s team has uncovered ‘switch sites,’ druggable regions that are key targets for transcription factor regulation to address mutations that cause disease.

Register for Details

For more details on financing and valuation for Flare Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Flare Therapeutics.

Register Today

Flare Therapeutics investors also invested in these private companies

Eli Lilly
Pfizer Ventures
Invus Financial Advisors
Pavilion Capital Partners
Agent Capital
Eventide Asset Management
GordonMD Global Investments

Team

Management Team

Daphne Karydas
Chief Operating Officer & Chief Financial Officer
Jeanette Kohlbrenner
Interim Chief People Officer
Steven McKnight Ph.D
Co-Founder & Chairman of the Scientific Advisory Board
Fraydoon Rastinejad Ph.D
Co-Founder
Mitchell Lazar Ph.D
Co-Founder
Amit Rakhit MD
Chief Executive Officer & President
Robert Sims Ph.D
Co-Founder & Chief Scientific Officer

Board Members

Aaron Davis
Boxer Capital
Craig Gordon MD
GordonMD Global Investments
Irena Melnikova Ph.D
Pfizer Ventures
Jakob Loven Ph.D
Nextech Invest
Lorence Kim MD
Third Rock Ventures
Steve Paul MD
Third Rock Ventures

Other companies like Flare Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B